Related Experiment Video
Updated: Mar 12, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Update on Lupus Nephritis
Salem Almaani1, Alexa Meara, Brad H Rovin
1Department of Internal Medicine, The Ohio State Wexner Medical Center, Columbus, Ohio.
Insights
Systemic lupus erythematosus (SLE) can cause lupus nephritis, a kidney disease. This review focuses on recent advances in understanding and managing lupus nephritis to preserve long-term kidney function.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs.
- Kidney involvement, known as lupus nephritis, occurs in approximately 50% of SLE patients.
- Lupus nephritis significantly increases morbidity and mortality, often leading to chronic kidney disease (CKD) or end-stage renal disease (ESRD).
Purpose of the Study:
- To review recent advancements in the epidemiology, genetics, and pathogenesis of lupus nephritis.
- To outline a framework for patient-specific management strategies for lupus nephritis.
- To emphasize the goal of preserving long-term kidney function in patients with SLE.
Main Methods:
- Comprehensive literature review of recent studies on lupus nephritis.
- Analysis of current understanding of disease mechanisms and genetic factors.
- Synthesis of updated therapeutic approaches and management guidelines.
Main Results:
- Recent research has expanded the understanding of SLE and lupus nephritis epidemiology and genetics.
- New insights into pathogenesis provide targets for novel therapies.
- Current treatments, while potent, still result in significant rates of CKD/ESRD, highlighting the need for improved management.
Conclusions:
- Effective management of lupus nephritis requires a patient-specific approach.
- Focusing on early diagnosis, understanding individual risk factors, and tailored treatment is crucial.
- Continued research and updated management frameworks are essential to improve long-term kidney outcomes for SLE patients.
Abstract:
SLE is a chronic inflammatory disease that affects the kidneys in about 50% of patients. Lupus nephritis is a major risk factor for overall morbidity and mortality in SLE, and despite potent anti-inflammatory and immunosuppressive therapies still ends in CKD or ESRD for too many patients. This review highlights recent updates in our understanding of disease epidemiology, genetics, pathogenesis, and treatment in an effort to establish a framework for lupus nephritis management that is patient-specific and oriented toward maintaining long-term kidney function in patients with lupus.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome I : Introduction
Nephrons
Nephrotic Syndrome II : Assessment and Medical Management
Acute Pyelonephritis I: Introduction
Nephrotic Syndrome III : Nursing Management

